EMA Begins Publishing Names of GMP-Deficient Drugmakers

December 27, 2013
In a new enforcement initiative intended to boost drugmaker quality, the European Medicines Agency (EMA) has begun publishing the names of manufacturing facilities that fall out of compliance with good manufacturing practices (GMP). The agency updated its EudraGMDP database to include the new noncompliance list, which currently includes 83 reports of GMP-deficient companies dating back to 2007.
Drug Industry Daily